Skip to main content

Knowledge for Growth - Postponed to September

Novosanis team members will attend the Knowledge for Growth congress in Ghent, Belgium; which will take place on 10 September 2020. Our team is excited to meet you there and give you more information about our unique urine capturing device Colli-Pee. This info will be shared by presenting a poster, or through an oral presentation.

Meet Koen Beyers, Vanessa Vankerckhoven, Stephanie Jordaens and Quinten van Avondt at Knowledge for Growth to learn more about the benefits of the Colli-Pee device.

Disclaimer

Novosanis is a wholly owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology. The Colli-Pee® family, the heart of the company, allows volumetric and standardized collection of first-void urine. The platform consists of variants capturing a range of urine volumes for different application purposes. Urine collection through the Colli-Pee® device is easy, comfortable, and more accurate than a regular urine cup. First-void urine has shown to improve detection of infectious diseases, including sexually transmitted infections as well as for some cancers applications. The Colli-Pee® device enables immediate mixing of the first-void urine sample with a preservative, improving stability of the urine specimen. Novosanis markets its products worldwide and has a global customer base.